Matches in SemOpenAlex for { <https://semopenalex.org/work/W3042573313> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3042573313 endingPage "2151" @default.
- W3042573313 startingPage "2151" @default.
- W3042573313 abstract "We compliment the discussion by Brindisi et al1 on the management of allergic rhinitis in children amid novel coronavirus disease 2019 (COVID-19) pandemic. Brindisi et al1 presented a well-reasoned discussion on the use of intranasal corticosteroids and allergen immunotherapy in children with allergic rhinitis amid COVID-19 pandemic where they recommend continuation of the former while withholding of the latter upon risk-benefit assessment. Besides the two approaches described by the authors, we feel that montelukast can be useful in paediatric patients who could not tolerate or demonstrate a satisfactory technique for or refused corticosteroid nasal sprays. In the management of allergic rhinitis, montelukast is similarly effective to oral antihistamines though less effective than corticosteroid nasal sprays. Nevertheless, montelukast is a potent cysteinyl leukotriene receptor antagonist where it not only acts by directly blocking leukotriene receptors but also possesses anti-inflammatory effects and suppressive actions on cytokine production. Therefore, it may be effective in mitigating cytokine storm associated with COVID-19. In fact, computational model indicated a possible role of montelukast in binding to the catalytic site of the main protease of severe acute respiratory syndrome coronavirus 2, the pathogen responsible for COVID-19, which may modulate and inhibit viral replication.2 It has been recently reported that elderly asthmatic patients receiving montelukast had a significant reduction in the acquisition of COVID-19 compared to those without receiving montelukast.3 Whether montelukast can be effective to decrease the risk of acquisition or to prevent severe outcomes from COVID-19 among paediatric patients needs to be confirmed in clinical trials. We nonetheless feel that montelukast should be considered by paediatricians to manage allergic rhinitis amid the COVID-19 pandemic considering its potential anti-inflammatory action and anti-viral activity. We declare no potential conflict of interest." @default.
- W3042573313 created "2020-07-23" @default.
- W3042573313 creator A5070482896 @default.
- W3042573313 creator A5076366979 @default.
- W3042573313 date "2020-08-08" @default.
- W3042573313 modified "2023-09-27" @default.
- W3042573313 title "Montelukast in children with allergic rhinitis amid COVID‐19 pandemic" @default.
- W3042573313 cites W3037917209 @default.
- W3042573313 cites W3038202667 @default.
- W3042573313 doi "https://doi.org/10.1111/apa.15491" @default.
- W3042573313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7405029" @default.
- W3042573313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32686128" @default.
- W3042573313 hasPublicationYear "2020" @default.
- W3042573313 type Work @default.
- W3042573313 sameAs 3042573313 @default.
- W3042573313 citedByCount "3" @default.
- W3042573313 countsByYear W30425733132021 @default.
- W3042573313 countsByYear W30425733132022 @default.
- W3042573313 countsByYear W30425733132023 @default.
- W3042573313 crossrefType "journal-article" @default.
- W3042573313 hasAuthorship W3042573313A5070482896 @default.
- W3042573313 hasAuthorship W3042573313A5076366979 @default.
- W3042573313 hasBestOaLocation W30425733131 @default.
- W3042573313 hasConcept C126322002 @default.
- W3042573313 hasConcept C203014093 @default.
- W3042573313 hasConcept C2776042228 @default.
- W3042573313 hasConcept C2776322731 @default.
- W3042573313 hasConcept C2776452501 @default.
- W3042573313 hasConcept C2779134260 @default.
- W3042573313 hasConcept C2779559532 @default.
- W3042573313 hasConcept C2780212800 @default.
- W3042573313 hasConcept C3008058167 @default.
- W3042573313 hasConcept C524204448 @default.
- W3042573313 hasConcept C71924100 @default.
- W3042573313 hasConcept C85663871 @default.
- W3042573313 hasConcept C89623803 @default.
- W3042573313 hasConceptScore W3042573313C126322002 @default.
- W3042573313 hasConceptScore W3042573313C203014093 @default.
- W3042573313 hasConceptScore W3042573313C2776042228 @default.
- W3042573313 hasConceptScore W3042573313C2776322731 @default.
- W3042573313 hasConceptScore W3042573313C2776452501 @default.
- W3042573313 hasConceptScore W3042573313C2779134260 @default.
- W3042573313 hasConceptScore W3042573313C2779559532 @default.
- W3042573313 hasConceptScore W3042573313C2780212800 @default.
- W3042573313 hasConceptScore W3042573313C3008058167 @default.
- W3042573313 hasConceptScore W3042573313C524204448 @default.
- W3042573313 hasConceptScore W3042573313C71924100 @default.
- W3042573313 hasConceptScore W3042573313C85663871 @default.
- W3042573313 hasConceptScore W3042573313C89623803 @default.
- W3042573313 hasIssue "10" @default.
- W3042573313 hasLocation W30425733131 @default.
- W3042573313 hasLocation W30425733132 @default.
- W3042573313 hasLocation W30425733133 @default.
- W3042573313 hasOpenAccess W3042573313 @default.
- W3042573313 hasPrimaryLocation W30425733131 @default.
- W3042573313 hasRelatedWork W1606916251 @default.
- W3042573313 hasRelatedWork W2021343253 @default.
- W3042573313 hasRelatedWork W2043240135 @default.
- W3042573313 hasRelatedWork W2088884463 @default.
- W3042573313 hasRelatedWork W3021260464 @default.
- W3042573313 hasRelatedWork W3181073615 @default.
- W3042573313 hasRelatedWork W4205986989 @default.
- W3042573313 hasRelatedWork W4299148371 @default.
- W3042573313 hasRelatedWork W4376614469 @default.
- W3042573313 hasRelatedWork W2089544806 @default.
- W3042573313 hasVolume "109" @default.
- W3042573313 isParatext "false" @default.
- W3042573313 isRetracted "false" @default.
- W3042573313 magId "3042573313" @default.
- W3042573313 workType "article" @default.